Skip to content
Home/Companies/Healthcare/Active Biomarkers

Active Biomarkers

Healthcare·France·Exited 2022·Held 2yr
Entry
2020
Hold
2yr
Exit
2022

Who owns Active Biomarkers?

Active Biomarkers is a French Healthcare company, now owned by KCAS Bioanalytical and Biomarker Services, which acquired it in 2022 from Turenne Groupe.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Turenne Groupe
Investor
Turenne Groupe
Capital Santé 2 · 2020 · Growth

Key facts

HQFrance
SectorHealthcare
Exit Type
Trade Sale
Buyer
KCAS Bioanalytical and Biomarker Services
Exit Year
2022

More from Capital Santé 2

Other portfolio companies in the same fund.

Le Petit Souk
Active
ConsumerFrance· 2026
M&C3i
Active
SoftwareFrance· 2026
Agrotech
Active
ConstructionFrance· 2025
Anothercorp.
Active
ConsumerFrance· 2025
Groupe Colibri – Promesse de Fleurs
Active
ConsumerFrance· 2025
Kimialys
Active
IndustrialsFrance· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Active Biomarkers?

Active Biomarkers is now owned by KCAS Bioanalytical and Biomarker Services, which acquired it in 2022 from Turenne Groupe.

When did KCAS Bioanalytical and Biomarker Services acquire Active Biomarkers?

KCAS Bioanalytical and Biomarker Services acquired Active Biomarkers in 2022, buying from Turenne Groupe.

Who did Active Biomarkers sell to?

Turenne Groupe sold Active Biomarkers to KCAS Bioanalytical and Biomarker Services in 2022 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue